The clock is ticking for Takeda (NASDAQOTH:TKPYY). Following its announcement late last month that it's considering an acquisition of Shire (NASDAQ:SHPG), it has until April 25, 2018, to present the latter's board of directors with an offer or walk away empty-handed. If it does make a bid, it could create a global company with about $30 billion in sales. However, this deal could be costly.
privacy policy | terms of use | contact us | advertise | pharma jobs | pharma blogs | facebook | twitter
Copyright © 2025,